The Latest Analyst Ratings for Treace Medical Concepts
Portfolio Pulse from Benzinga Insights
Treace Medical Concepts (NASDAQ:TMCI) has received 3 bullish and 2 indifferent analyst ratings in the last quarter. The company's average 12-month price target is $26.2, a decrease of 14.57% from the previous average price target of $30.67.
September 29, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Treace Medical Concepts has received mixed analyst ratings, with a decreased 12-month price target.
The mixed analyst ratings indicate uncertainty about the company's performance. The decrease in the 12-month price target suggests that analysts have lowered their expectations for the company's stock price, which could potentially impact investor sentiment and the stock's price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100